» Articles » PMID: 18088600

S1P(2) Receptors Mediate Inhibition of Glioma Cell Migration Through Rho Signaling Pathways Independent of PTEN

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2007 Dec 20
PMID 18088600
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Sphingosine 1-phosphate (S1P) induced the inhibition of glioma cell migration. Here, we characterized the signaling mechanisms involved in the inhibitory action by S1P. In human GNS-3314 glioblastoma cells, the S1P-induced inhibition of cell migration was associated with activation of RhoA and suppression of Rac1. The inhibitory action of S1P was recovered by a small interference RNA specific to S1P(2) receptor, a carboxyl-terminal region of Galpha12 or Galpha13, an RGS domain of p115RhoGEF, and a dominant-negative mutant of RhoA. The inhibitory action of S1P through S1P(2) receptors was also observed in both U87MG glioblastoma and 1321N1 astrocytoma cells, which have no protein expression of a phosphatase and tensin homolog deleted on chromosome 10 (PTEN). These results suggest that S1P(2) receptors/G(12/13)-proteins/Rho signaling pathways mediate S1P-induced inhibition of glioma cell migration. However, PTEN, recently postulated as an indispensable molecule for the inhibition of cell migration, may not be critical for the S1P(2) receptor-mediated action in glioma cells.

Citing Articles

The relationship between sphingosine-1-phosphate receptor 2 and epidermal growth factor in migration and invasion of oral squamous cell carcinoma.

Wongviriya A, Shelton R, Cooper P, Milward M, Landini G Cancer Cell Int. 2023; 23(1):65.

PMID: 37038210 PMC: 10088162. DOI: 10.1186/s12935-023-02906-w.


Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma Progression.

Arseni L, Sharma R, Mack N, Nagalla D, Ohl S, Hielscher T Cancers (Basel). 2023; 15(2).

PMID: 36672428 PMC: 9856301. DOI: 10.3390/cancers15020479.


Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape.

Li S, Chen J, Chen X, Yu J, Guo Y, Li M Front Pharmacol. 2022; 13:997664.

PMID: 36110544 PMC: 9468875. DOI: 10.3389/fphar.2022.997664.


An Insight into GPCR and G-Proteins as Cancer Drivers.

Chaudhary P, Kim S Cells. 2021; 10(12).

PMID: 34943797 PMC: 8699078. DOI: 10.3390/cells10123288.


Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate.

Hawkins C, Ali T, Ramanadham S, Hjelmeland A Biomolecules. 2020; 10(10).

PMID: 32977496 PMC: 7598277. DOI: 10.3390/biom10101357.